Stay updated on Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding status notice and updated version to v3.2.0; removed the previous v3.1.0 reference.
    Difference
    13%
    Check dated 2025-10-05T14:29:23.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T09:46:51.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2.
    Difference
    0.3%
    Check dated 2025-09-14T00:18:21.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.3%
    Check dated 2025-09-06T21:08:06.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms and details have been removed.
    Difference
    4%
    Check dated 2025-08-30T15:36:14.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T11:55:37.000Z thumbnail image

Stay in the know with updates to Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.